Measuring quality of life in COPD patients: comparing disease-specific supplements to the EQ-5D-5L

References

• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Eur Respir J. 2017 Mar;49(3):1700214.
   Web of Science ®Google Scholar
• World Health Organization. The top 10 causes of death [updated 13.06.2018]. [cited 2018 Jun 13]. Available from: http://www.who.int/en/news-room/fact-sheets/detail/the-top-10-causes-of-death
   Google Scholar
• Wacker ME, Jorres RA, Karch A, et al. Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities. BMC Pulm Med. 2016 May 10;16(1):70.
   PubMed Web of Science ®Google Scholar
• Wacker ME, Jorres RA, Karch A, et al. Relative impact of COPD and comorbidities on generic health-related quality of life: a pooled analysis of the COSYCONET patient cohort and control subjects from the KORA and SHIP studies. Respir Res. 2016 Jul 12;17(1):81.
   PubMed Web of Science ®Google Scholar
• Weldam SW, Schuurmans MJ, Liu R, et al. Evaluation of quality of life instruments for use in COPD care and research: a systematic review. Int J Nurs Stud. 2013 May;50(5):688–707.
   PubMed Web of Science ®Google Scholar
• Rabin R, Gudex C, Selai C, et al. From translation to version management: a history and review of methods for the cultural adaptation of the EuroQol five-dimensional questionnaire. Value Health. 2014 Jan-Feb;17(1):70–76.
   PubMed Web of Science ®Google Scholar
• Leidl R, Reitmeir P. An experience-based value set for the EQ-5D-5L in Germany. Value Health. 2017;20:1150–1156.
   Web of Science ®Google Scholar
• Ludwig K, Graf von der Schulenburg JM, Greiner W. German value set for the EQ-5D-5L. PharmacoEconomics. 2018 Jun;36(6):663–674.
   PubMed Web of Science ®Google Scholar
• Weinstein MC, Torrance G, McGuire A. QALYs: the basics. Value Health. 2009 Mar;12(Suppl 1):S5–9.
   PubMed Web of Science ®Google Scholar
• Claxton K, Martin S, Soares M, et al. Methods for the estimation of the national institute for health and care excellence cost-effectiveness threshold. Health Technol Assess. 2015 Feb;19(14):1-vi.
   PubMed Web of Science ®Google Scholar
• Whitehead SJ, Ali S. Health outcomes in economic evaluation: the QALY and utilities. Br Med Bull. 2010;96:5–21.
   PubMed Web of Science ®Google Scholar
• Shah KK, Mulhern B, Longworth L, et al. Views of the UK general public on important aspects of health not captured by EQ-5D. Patient. 2017 Dec;10(6):701–709.
   PubMedGoogle Scholar
• Szentes BL, Kreuter M, Bahmer T, et al. Quality of life assessment in interstitial lung diseases: acomparison of the disease-specific K-BILD with the generic EQ-5D-5L. Respir Res. 2018 May 25;19(1):101.
   PubMedGoogle Scholar
• Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011 Dec;20(10):1727–1736.
   PubMed Web of Science ®Google Scholar
• Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34:648–654.
   Web of Science ®Google Scholar
• van der Molen T, Willemse BW, Schokker S, et al. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes. 2003 Apr;28(1):13.
   Google Scholar
• Clinical COPD Questionnaire. Scoring the clinical COPD questionnaire. [cited 2018 Mar 15]. Available from: http://ccq.nl/?page_id=15
   Google Scholar
• Meguro M, Barley EA, Spencer S, et al. Development and validation of an improved, COPD-specific version of the St. George respiratory questionnaire. Chest. 2007 Aug;132(2):456–463.
   PubMed Web of Science ®Google Scholar
• Cooper BG, Stocks J, Hall GL, et al. The global lung function initiative (GLI) network: bringing the world’s respiratory reference values together. Breathe (Sheff). 2017 Sep;13(3):e56–e64.
   PubMedGoogle Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD [cited 2017]. Available from: http://goldcopd.org2017
   Google Scholar
• Stenton C. The MRC breathlessness scale. Occup Med (Lond). 2008 May;58(3):226–227.
   PubMed Web of Science ®Google Scholar
• Palfreyman S, Mulhern B. The psychometric performance of generic preference-based measures for patients with pressure ulcers. Health Qual Life Outcomes. 2015 Aug;01(13):117.
   Google Scholar
• McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res. 1995 Aug;4(4):293–307.
   PubMed Web of Science ®Google Scholar
• Nolan CM, Longworth L, Lord J, et al. The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference. Thorax. 2016 Jun;71(6):493–500.
   PubMed Web of Science ®Google Scholar
• Garcia-Gordillo MA, Collado-Mateo D, Olivares PR, et al. A cross-sectional assessment of health-related quality of life among patients with chronic obstructive pulmonary disease. Iran J Public Health. 2017 Aug;46(8):1046–1053.
   PubMed Web of Science ®Google Scholar
• Lin FJ, Pickard AS, Krishnan JA, et al. Measuring health-related quality of life in chronic obstructive pulmonary disease: properties of the EQ-5D-5L and PROMIS-43 short form. BMC Med Res Methodol. 2014 Jun 16;14:78.
   PubMed Web of Science ®Google Scholar
• Jones PW. Health status measurement in chronic obstructive pulmonary disease. Thorax. 2001 Nov;56(11):880–887.
   PubMed Web of Science ®Google Scholar
• Allison PJ, Locker D, Feine JS. Quality of life: a dynamic construct. Soc Sci Med. 1997 Jul;45(2):221–230.
   PubMed Web of Science ®Google Scholar
• Huber MB, Reitmeir P, Vogelmann M, et al. EQ-5D-5L in the general German population: comparison and evaluation of three yearly cross-section surveys. Int J Environ Res Public Health. 2016 Mar 21;13(3):12.
   PubMed Web of Science ®Google Scholar